Naba Al Saha Medical Services Company Statistics
Total Valuation
Naba Al Saha Medical Services Company has a market cap or net worth of SAR 840.00 million. The enterprise value is 884.61 million.
Market Cap | 840.00M |
Enterprise Value | 884.61M |
Important Dates
The next estimated earnings date is Thursday, November 28, 2024.
Earnings Date | Nov 28, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Naba Al Saha Medical Services Company has 10.50 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 10.50M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 69.44% |
Owned by Institutions (%) | 0.00% |
Float | 1.95M |
Valuation Ratios
The trailing PE ratio is 22.31.
PE Ratio | 22.31 |
Forward PE | n/a |
PS Ratio | 4.27 |
PB Ratio | 4.35 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.07, with an EV/FCF ratio of -47.82.
EV / Earnings | 23.49 |
EV / Sales | 4.50 |
EV / EBITDA | 18.07 |
EV / EBIT | 22.77 |
EV / FCF | -47.82 |
Financial Position
The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.28.
Current Ratio | 3.49 |
Quick Ratio | 3.08 |
Debt / Equity | 0.28 |
Debt / EBITDA | 1.07 |
Debt / FCF | -2.90 |
Interest Coverage | 184.82 |
Financial Efficiency
Return on equity (ROE) is 21.59% and return on invested capital (ROIC) is 11.55%.
Return on Equity (ROE) | 21.59% |
Return on Assets (ROA) | 9.72% |
Return on Capital (ROIC) | 11.55% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.77 |
Inventory Turnover | 10.89 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.49% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +33.49% |
50-Day Moving Average | 83.33 |
200-Day Moving Average | 87.10 |
Relative Strength Index (RSI) | 58.42 |
Average Volume (20 Days) | 4,104 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Naba Al Saha Medical Services Company had revenue of SAR 196.78 million and earned 37.66 million in profits. Earnings per share was 3.59.
Revenue | 196.78M |
Gross Profit | 69.67M |
Operating Income | 39.87M |
Pretax Income | 40.45M |
Net Income | 37.66M |
EBITDA | 48.39M |
EBIT | 39.87M |
Earnings Per Share (EPS) | 3.59 |
Balance Sheet
The company has 9.00 million in cash and 53.61 million in debt, giving a net cash position of -44.61 million or -4.25 per share.
Cash & Cash Equivalents | 9.00M |
Total Debt | 53.61M |
Net Cash | -44.61M |
Net Cash Per Share | -4.25 |
Equity (Book Value) | 193.14M |
Book Value Per Share | 18.39 |
Working Capital | 86.14M |
Cash Flow
In the last 12 months, operating cash flow was 35.84 million and capital expenditures -54.34 million, giving a free cash flow of -18.50 million.
Operating Cash Flow | 35.84M |
Capital Expenditures | -54.34M |
Free Cash Flow | -18.50M |
FCF Per Share | -1.76 |
Margins
Gross margin is 35.41%, with operating and profit margins of 20.26% and 19.14%.
Gross Margin | 35.41% |
Operating Margin | 20.26% |
Pretax Margin | 20.56% |
Profit Margin | 19.14% |
EBITDA Margin | 24.59% |
EBIT Margin | 20.26% |
FCF Margin | -9.40% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.24%.
Dividend Per Share | 0.20 |
Dividend Yield | 0.24% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 5.58% |
Buyback Yield | n/a |
Shareholder Yield | 0.24% |
Earnings Yield | 4.48% |
FCF Yield | -2.20% |
Stock Splits
The last stock split was on November 20, 2023. It was a forward split with a ratio of 1.5.
Last Split Date | Nov 20, 2023 |
Split Type | Forward |
Split Ratio | 1.5 |
Scores
Naba Al Saha Medical Services Company has an Altman Z-Score of 6.37.
Altman Z-Score | 6.37 |
Piotroski F-Score | n/a |